Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

NCT04305145 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Melanoma Stage III
Melanoma Stage IV
Skin Cancer Stage III
Skin Cancer Stage IV
Drug-Induced Colitis
Drug Toxicity
Immune-related Adverse Event

Interventions

DRUG: Infliximab
DRUG: Methylprednisolone
DRUG: Prednisone

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]